SCHEMBL30309495

SCHEMBL30309495

COc1ccc(N2C(=O)N(c3c(C(F)F)csc3Cl)Cc3cnc(Cl)nc32)nc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIK2 Q9H0K1 2/20 0.47
CSF1R P07333 1/20 0.43
SIK1 P57059 1/20 0.43
SIK3 Q9Y2K2 1/20 0.43
FGFR4 P22455 14/20 0.33
FGFR1 P11362 11/20 0.33
FGFR2 P21802 6/20 0.32
FGFR3 P22607 5/20 0.32
KDR P35968 2/20 0.32
EGFR P00533 1/20 0.30
FYN P06241 1/20 0.30
PDGFRB P09619 1/20 0.30
PDGFRA P16234 1/20 0.30
PRKACA P17612 1/20 0.30
PRKACG P22612 1/20 0.30
PRKACB P22694 1/20 0.30
MAPK1 P28482 1/20 0.30
EPHB3 P54753 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30309533 0.88 SIK2 (0.51) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL23978120 0.88 SIK2 (0.51) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL30309486 0.86 SIK2 (0.46) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL25882416 0.86 SIK2 (0.46) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL25881926 0.81 CSF1R (0.60) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL30309539 0.81 CSF1R (0.60) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL25313125 0.79 SIK2 (0.73) SIK2CSF1RSIK1SIK3EGFR
SCHEMBL25882519 0.79 SIK2 (0.69) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL23978372 0.79 SIK2 (0.68) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL23978178 0.79 SIK2 (0.51) SIK2CSF1RSIK1SIK3FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143191-A2 BICYCLIC KINASE INHIBITORS AND USES THEREOF iOmx Therapeutics AG (DE) 2023-03-08 EP disclosed